CY1111048T1 - Ενωσεις που εμφανιζουν αντικαρκινικη δραστηριοτητα - Google Patents

Ενωσεις που εμφανιζουν αντικαρκινικη δραστηριοτητα

Info

Publication number
CY1111048T1
CY1111048T1 CY20101100990T CY101100990T CY1111048T1 CY 1111048 T1 CY1111048 T1 CY 1111048T1 CY 20101100990 T CY20101100990 T CY 20101100990T CY 101100990 T CY101100990 T CY 101100990T CY 1111048 T1 CY1111048 T1 CY 1111048T1
Authority
CY
Cyprus
Prior art keywords
unions
cancer activity
displaying anti
displaying
cancer
Prior art date
Application number
CY20101100990T
Other languages
English (en)
Inventor
Gianfranco Peluso
Menotti Calvani
Original Assignee
Defiante Farmacêutica, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Defiante Farmacêutica, S.A. filed Critical Defiante Farmacêutica, S.A.
Publication of CY1111048T1 publication Critical patent/CY1111048T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Αποκαλύπτεται η χρήση ενώσεων του χημικού τύπου (I), όπου τα Χ, Υ και Ζ είναι όπως ορίζονται στην περιγραφή της εφεύρεσης, για την παρασκευή αντικαρκινικού φαρμάκου, προαιρετικά σε συνδυασμό με κατά διαφορετικό τρόπο βιολογικά ενεργές ουσίες.
CY20101100990T 2004-02-12 2010-11-03 Ενωσεις που εμφανιζουν αντικαρκινικη δραστηριοτητα CY1111048T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000230A ITMI20040230A1 (it) 2004-02-12 2004-02-12 Composti ad attivita' antitumorale
EP05707260A EP1713461B1 (en) 2004-02-12 2005-02-08 Compounds having antitumor activity

Publications (1)

Publication Number Publication Date
CY1111048T1 true CY1111048T1 (el) 2015-06-11

Family

ID=34856910

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20101100990T CY1111048T1 (el) 2004-02-12 2010-11-03 Ενωσεις που εμφανιζουν αντικαρκινικη δραστηριοτητα

Country Status (20)

Country Link
US (1) US7652066B2 (el)
EP (1) EP1713461B1 (el)
JP (1) JP2007522165A (el)
KR (1) KR101220331B1 (el)
CN (1) CN1917867B (el)
AR (1) AR047742A1 (el)
AT (1) ATE476973T1 (el)
AU (1) AU2005211906B2 (el)
BR (1) BRPI0507664A (el)
CA (1) CA2556069C (el)
CY (1) CY1111048T1 (el)
DE (1) DE602005022828D1 (el)
DK (1) DK1713461T3 (el)
ES (1) ES2350695T3 (el)
HK (1) HK1099687A1 (el)
IT (1) ITMI20040230A1 (el)
PL (1) PL1713461T3 (el)
SI (1) SI1713461T1 (el)
TW (1) TWI361802B (el)
WO (1) WO2005077354A1 (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8314144B2 (en) * 2004-02-12 2012-11-20 Defiante Farmaceutica, S.A. Compounds having antitumor activity
US8410150B2 (en) 2007-03-09 2013-04-02 University Health Network Inhibitors of carnitine palmitoyltransferase and treating cancer
CA2694724C (en) 2007-08-01 2017-09-12 University Health Network Cyclic inhibitors of carnitine palmitoyltransferase and treating cancer
KR101225223B1 (ko) * 2008-04-29 2013-01-22 에프. 호프만-라 로슈 아게 4-다이메틸아미노부티르산 유도체
US20110230555A1 (en) * 2008-06-24 2011-09-22 David Middlemiss Enzyme Inhibitors and the Use Thereof
JP5746988B2 (ja) * 2012-02-15 2015-07-08 ライオン株式会社 カプセル皮膜及びカプセル

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1299266B1 (it) 1998-05-15 2000-02-29 Sigma Tau Ind Farmaceuti Inibitori reversibili della carnitina palmitoil trasferasi
KR20090130151A (ko) * 1999-11-12 2009-12-17 더 존스 홉킨스 유니버시티 세포내 말로닐 ＣｏＡ의 수준을 증가시킴에 의한 암의 치료 방법

Also Published As

Publication number Publication date
CN1917867A (zh) 2007-02-21
AR047742A1 (es) 2006-02-15
ES2350695T3 (es) 2011-01-26
JP2007522165A (ja) 2007-08-09
KR20060134059A (ko) 2006-12-27
EP1713461B1 (en) 2010-08-11
PL1713461T3 (pl) 2011-01-31
KR101220331B1 (ko) 2013-01-09
AU2005211906B2 (en) 2009-07-30
DE602005022828D1 (de) 2010-09-23
TWI361802B (en) 2012-04-11
TW200530154A (en) 2005-09-16
CA2556069A1 (en) 2005-08-25
EP1713461A1 (en) 2006-10-25
BRPI0507664A (pt) 2007-07-17
HK1099687A1 (en) 2007-08-24
CN1917867B (zh) 2011-03-16
ATE476973T1 (de) 2010-08-15
WO2005077354A1 (en) 2005-08-25
US7652066B2 (en) 2010-01-26
US20080227683A1 (en) 2008-09-18
AU2005211906A1 (en) 2005-08-25
ITMI20040230A1 (it) 2004-05-12
DK1713461T3 (da) 2010-11-22
CA2556069C (en) 2013-04-23
SI1713461T1 (sl) 2010-12-31

Similar Documents

Publication Publication Date Title
CY1122646T1 (el) Δικυκλικες ετεροαρυλ ενωσεις
CY1119534T1 (el) Παραγωγα φωσφορου ως αναστολεις κινασης
ATE433961T1 (de) Ansamycine mit verbesserten pharmakologischen und biologischen eigenschaften
CY1118874T1 (el) Ανθρωποποιημενα αντισωματα εναντια στη liv-1 και χρηση αυτων για τη θεραπευτικη αντιμετωπιση του καρκινου
CY1111048T1 (el) Ενωσεις που εμφανιζουν αντικαρκινικη δραστηριοτητα
SE0302811D0 (sv) Novel compounds
CY1122349T1 (el) Παραγωγα 1-benzyλ-3-υδροξυμεθυλινδαζολης και χρηση αυτων στη θεραπεια νοσων που βασιζονται στην εκφραση των mcp-1, cxcr1 και ρ40
CY1112886T1 (el) Ανοσοκατασταλτικος παραγοντας ο οποιος περιλαμβανει μια ετεροκυκλικη ενωση ως δραστικο συστατικο
CY1110419T1 (el) Τρικυκλικες ενωσεις με βαση το 1,6-διυδρο-1,3,5,6-tetpaaza-as-ινδακενιο και φαρμακευτικες συνθεσεις που τις περιεχουν ως αναστολεις της ενζυμικης ενεργοτητας της ικκ
ATE467413T1 (de) Oxindolderivate als antikrebsmittel
CY1110132T1 (el) Παραγωγα ουριας τροπανιου, η παρασκευη τους και οι εφαρμογες τους στη θεραπευτικη
CY1107851T1 (el) Παραγωγα πυρολλο-πυριδινης και η χρηση τους ως ανταγωνιστων crth2
CY1110247T1 (el) Παραγωγα βενζοκιναζολινης και η χρηση τους στην θεραπεια των διαταραχων των οστων
CY1114737T1 (el) Παραγωγα κινοξαλινδιονης
CY1114793T1 (el) Παραγωγα αμινοπυραζολιου
CY1107419T1 (el) Προφαρμακα αντι-ιικων μεσων απο πιπεραζινη και υποκατεστημενη πιπεριδινη
CY1109010T1 (el) γ-ΚΡΥΣΤΑΛΛΙΚΗ ΜΟΡΦΗ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ ΙΒΑΒΡΑΔΙΝΗΣ, ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΤΗΣ ΚΑΙ ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΤΗΝ ΠΕΡΙΕΧΟΥΝ
SE0301700D0 (sv) Novel compounds
CY1111903T1 (el) Σπειροκυκλικα παραγωγα κυκλοεξανιου με αναλγητικη δραση
ATE447562T1 (de) Verstärker von glutamat-rezeptoren
BRPI0508894A (pt) meios para administração transdérmica de nicotina e uso
CY1116641T1 (el) Ενωσεις πυραζολιου ως ανταγωνιστες crth2
DE602005009255D1 (de) Amid-prodrug von gemcitabin, zusammensetzungen und verwendung damit
SV2008002952A (es) Uso de derivados de sulfamida heterociclica benzo-fusionada para el tratamiento de obesidad referencia cruzada a solicitudes relacionadas ref. prd2586sv
ATE477805T1 (de) 9a-carbamoyl-y-aminopropyl- und 9a-thiocarbamoyl- y-aminopropyl-azalide mit antimalaria-aktivität